Thrombectomy with or without thrombolysis in patients with acute ischemic stroke: a systematic review and meta-analysis.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 05 06 2021
accepted: 06 09 2021
revised: 06 09 2021
pubmed: 15 9 2021
medline: 25 3 2022
entrez: 14 9 2021
Statut: ppublish

Résumé

Recently, several randomized controlled trials (RCTs) about direct mechanical thrombectomy (d-MT) vs. intravenous thrombolysis before MT (IVT + MT) for acute ischemic stroke (AIS) patients have been reported. This study aims to investigate the differences in efficacy and safety of MT with or without IVT for the treatment of patients with AIS. MEDLINE, EMBASE, Cochrane Library and Clinicaltrials.gov from March 2011 to February 2021 were systematically searched for studies comparing the two strategies directly. Review Manager 5.3 software was used to assess the risk of bias and pool the data with a random effect model. We pooled 1633 patients from 4 RCTs. The primary outcome, proportion of patients achieving functional independence (mRS0-2) at 90 days, was not significantly different between the two groups (MT 46.02% vs. IVT + MT 45.47%, OR 1.02; 95% CI 0.84-1.25). However, the risk of developing any ICH was lower in the d-MT group (RR 0.75; 95% CI 0.63-0.89). In addition, the remaining secondary outcomes, such as successful reperfusion (eTICI scale, 2b-3) at final angiogram (OR 0.80; 95% CI, 0.62-1.03) and mortality at 90 days (RR 1.06; 95% CI 0.85-1.31), did not differ between the groups. Outcomes were similar for d-MT and IVT + MT, with d-MT having a lower risk of any ICH. We need to focus on precision medicine in the future. URL: http://inplasy.com ; Unique identifier: INPLASY202130094.

Sections du résumé

BACKGROUND BACKGROUND
Recently, several randomized controlled trials (RCTs) about direct mechanical thrombectomy (d-MT) vs. intravenous thrombolysis before MT (IVT + MT) for acute ischemic stroke (AIS) patients have been reported. This study aims to investigate the differences in efficacy and safety of MT with or without IVT for the treatment of patients with AIS.
METHODS METHODS
MEDLINE, EMBASE, Cochrane Library and Clinicaltrials.gov from March 2011 to February 2021 were systematically searched for studies comparing the two strategies directly. Review Manager 5.3 software was used to assess the risk of bias and pool the data with a random effect model.
RESULTS RESULTS
We pooled 1633 patients from 4 RCTs. The primary outcome, proportion of patients achieving functional independence (mRS0-2) at 90 days, was not significantly different between the two groups (MT 46.02% vs. IVT + MT 45.47%, OR 1.02; 95% CI 0.84-1.25). However, the risk of developing any ICH was lower in the d-MT group (RR 0.75; 95% CI 0.63-0.89). In addition, the remaining secondary outcomes, such as successful reperfusion (eTICI scale, 2b-3) at final angiogram (OR 0.80; 95% CI, 0.62-1.03) and mortality at 90 days (RR 1.06; 95% CI 0.85-1.31), did not differ between the groups.
CONCLUSIONS CONCLUSIONS
Outcomes were similar for d-MT and IVT + MT, with d-MT having a lower risk of any ICH. We need to focus on precision medicine in the future.
REGISTRATION BACKGROUND
URL: http://inplasy.com ; Unique identifier: INPLASY202130094.

Identifiants

pubmed: 34519851
doi: 10.1007/s00415-021-10798-x
pii: 10.1007/s00415-021-10798-x
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1809-1816

Subventions

Organisme : Suzhou Health Talents Training Project
ID : GSWS2019002

Informations de copyright

© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46–e110
doi: 10.1161/STR.0000000000000158
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384(9958):1929–1935
doi: 10.1016/S0140-6736(14)60584-5
Muir KW (2016) Stroke in 2015: the year of endovascular treatment. Lancet Neurol 15(1):2–3
doi: 10.1016/S1474-4422(15)00337-3
Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA et al (2016) Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke 47(9):2373–2379
doi: 10.1161/STROKEAHA.116.013644
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50(12):e344–e418
doi: 10.1161/STR.0000000000000211
Fiehler J, Cognard C, Gallitelli M, Jansen O, Kobayashi A, Mattle HP et al (2016) European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS). Int J Stroke 11(6):701–716
doi: 10.1177/1747493016647735
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res Ed). 339:b2700
doi: 10.1136/bmj.b2700
Katsanos AH, Malhotra K, Goyal N, Arthur A, Schellinger PD, Kohrmann M et al (2019) Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions. Ann Neurol 86(3):395–406
doi: 10.1002/ana.25544
Kaesmacher J, Mordasini P, Arnold M, Lopez-Cancio E, Cerda N, Boeckh-Behrens T et al (2019) Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg 11(1):20–27
doi: 10.1136/neurintsurg-2018-013834
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 h after symptom onset in ischemic stroke. N Engl J Med 372(24):2296–2306
doi: 10.1056/NEJMoa1503780
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20
doi: 10.1056/NEJMoa1411587
Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W et al (2020) Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 382(21):1981–1993
doi: 10.1056/NEJMoa2001123
Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W et al (2021) Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA 325(3):234–243
doi: 10.1001/jama.2020.23523
Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y et al (2021) Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA 325(3):244–253
doi: 10.1001/jama.2020.23522
Treurniet KM, LeCouffe NE, Kappelhof M, Emmer BJ, van Es A, Boiten J et al (2021) MR CLEAN-NO IV: intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion-study protocol for a randomized clinical trial. Trials 22(1):141
doi: 10.1186/s13063-021-05063-5
Bellwald S, Weber R, Dobrocky T, Nordmeyer H, Jung S, Hadisurya J et al (2017) Direct mechanical intervention versus bridging therapy in stroke patients eligible for intravenous thrombolysis: a pooled analysis of 2 registries. Stroke 48(12):3282–3288
doi: 10.1161/STROKEAHA.117.018459
Wang Y, Wu X, Zhu C, Mossa-Basha M, Malhotra A (2021) Bridging thrombolysis achieved better outcomes than direct thrombectomy after large vessel occlusion: an updated meta-analysis. Stroke 52(1):356–365
doi: 10.1161/STROKEAHA.120.031477
Vidale S, Romoli M, Clemente AE (2021) Mechanical thrombectomy with or without thrombolysis: a meta-analysis of RCTs. Acta Neurol Scand 143:554–557
doi: 10.1111/ane.13390

Auteurs

Xin Wu (X)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China.
Department of Neurosurgery, Suzhou Ninth People's Hospital, Suzhou, 215200, China.

Yi Ge (Y)

Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu Province, China.

Shujun Chen (S)

Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu Province, China.

Zeya Yan (Z)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China.

Zilan Wang (Z)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China.

Wei Zhang (W)

Department of Neurosurgery, Suzhou Ninth People's Hospital, Suzhou, 215200, China.

Zhouqing Chen (Z)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China.

Tao Xue (T)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China. 2992326676@qq.com.
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100000, China. 2992326676@qq.com.

Zhong Wang (Z)

Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu Province, China. wangzhong761@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH